Dr. Axe Wire · Study decoded · health
Selenium-Enriched Proteins Ease Brain Inflammation and Memory Loss in Mice
A mouse study links specific selenium-protein forms to less brain inflammation and better memory after an inflammatory trigger.
- Who was studied: Mice given a bacterial toxin to trigger brain inflammation and memory loss, plus mouse brain immune cells tested separately in dishes.
- What it doesn't show: Whether these selenium protein forms work the same way in people.
Selenium speciation drives differential neuroprotection by Se-enriched plant proteins against neuroinflammation, published October 30, 2026 in Food & Function, found that selenium-enriched plant proteins eased brain inflammation and memory problems in mice, with the effect depending on the chemical form of selenium the protein carried.
Researchers gave mice a bacterial toxin that triggers brain inflammation and memory loss, then tested three selenium-enriched plant proteins, each carrying a different chemical form of selenium. All three eased the memory problems. One form, a selenocysteine-enriched protein, raised liver selenium levels alongside higher blood levels of a selenium-carrying protein called SEPP1, and lowered two brain immune-cell activation markers, GFAP and IBA-1, by 43.3% and 53.9% compared with untreated toxin-exposed mice.
A selenomethionine-enriched protein worked differently, reducing brain oxidative stress and cutting buildup of a plaque-linked protein fragment, amyloid-beta 1-42, by 69.2%. A third form, bound as selenate, gave weaker protection than the other two. In lab dish tests using mouse brain immune cells, selenium-enriched protein fragments calmed inflammatory activity more than low-selenium versions at the same protein amount.
The authors conclude that selenium's chemical form, not the protein structure itself, was more closely tied to the protective effects seen in this model. Selenium is a mineral the brain uses to build antioxidant enzymes and transport proteins like SEPP1 that carry it to tissues that need it.
Selenium-Enriched Protein Lowered Brain Markers in Mice
This is a mouse and cell-culture study using an induced inflammation model, not naturally occurring human brain disease. Whether these selenium-protein forms reach the human brain or affect human cognition the same way is untested; larger studies in people are the logical next step.
Dr. Axe’s Take
Different forms of selenium protected the mouse brain through different routes, one calming immune cell activation, another cutting oxidative stress and plaque buildup. That tells me the form selenium comes in matters, not just the total amount in a supplement label. I get my selenium from Brazil nuts, sardines, eggs and sunflower seeds, since whole foods deliver a natural mix of these compounds along with other cofactors the brain uses. For brain inflammation generally, I would pair those foods with turmeric, wild-caught fish and leafy greens, and protect sleep, since that's when the brain clears out inflammatory debris.
— Dr. AxeTake the Cellular Health Quiz →
Study summary
- Who
- Mice given a bacterial toxin to induce brain inflammation and memory impairment; mouse brain immune cells (BV-2) tested separately.
- Design
- Animal and cell-culture study comparing three selenium-enriched plant proteins with different selenium chemical forms against an untreated toxin-exposed group.
- Dose
- Three selenium-enriched protein types tested at matched selenium or protein concentrations; exact mg doses not reported.
- Primary result
- A selenocysteine-enriched protein lowered brain inflammation markers GFAP and IBA-1 by 43.3% and 53.9% versus untreated toxin-exposed mice.
- Secondary
- A selenomethionine-enriched protein cut brain amyloid-beta 1-42 buildup by 69.2% and reduced oxidative stress; a selenate-enriched protein gave weaker protection than the other two forms.
- Funding / conflicts
- Funders listed in the journal record: National Natural Science Foundation of China; Collaborative Innovation Center of Food Safety and Quality Control in Jiangsu Province. Conflicts not reported in the abstract.
- Date
- Oct 30, 2026



